Skip to main content

Growing Focus on Patient-Centered Healthcare led to Rise in Urgent Care Apps Market

Urgent care apps are intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring. 

 Treatment can be offered remotely via text/audio/video calls, or help can be arranged to usher the patient to the nearest hospital. The widespread adoption of smartphones and increased demand for urgent and convenient access to care will be crucial to the market’s growth. 

Urgent Care Apps Market


The global urgent care apps market was valued at $973.6 million in 2020 and is anticipated to grow to $10,150.5 million by the end of 2030 at a projected CAGR of 26.32% during the forecast period 2021-2030. 

 The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no visible impact of COVID-19 beyond 2030. The changes in the market during that timeline can build upon the developments of this decade.

The COVID-19 pandemic has positively impacted the global urgent care apps market due to factors such as shift in preference from at-clinic to at-home virtual care, technological advancements in healthcare, and improving internet connectivity.

COVID-19 impact on urgent care market


BIS RESEARCH’S TAKE ON THE INDUSTRY

What is the addressable market size and forecast based on region? 

The North America region has one of the most technologically advanced healthcare systems globally. The various factors propelling the growth of the regional market include increasing smartphone adoption and the presence of established as well as emerging players in the market. 

In Europe, evolving regulatory landscape and the government’s measures to bolster data privacy are the primary reasons contributing to the growth of the regional market.

The emergence of 5G technology is one of the major factors driving the growth of the urgent care apps market in Asia-Pacific.

What are the key trends of the global urgent care apps market? 

 The key technological trends anticipated to have maximum influence on the global urgent care apps market during the forecast period 2021-2030 include artificial intelligence for personalized care, shift from physical care to telemedicine, remote patient monitoring ecosystems, increasing smartphone penetration, and focus on the entire patient journey beyond diagnosis. 

 In the short term, i.e., during 2021-2025, the key trends anticipated to impact the global urgent care apps market include the ongoing shift from physical care to telemedicine and remote patient monitoring. This is due to factors such as technological advancements in cellular communications, such as the growth of 4G and 5G and government initiatives to promote telemedicine. The growth is anticipated to be considered in growing economies such as China, India, Brazil, and Mexico.

 In the long term, i.e., during 2025-2030, the key trend expected to disrupt the global urgent care apps market is the shift toward telemedicine. The integration of AI in healthcare is anticipated due to the rising awareness about the technology, its potential to streamline healthcare processes and enable physicians to make better decisions.

Key Trends On Urgent Care App Market

     
    What are the market shares of key competitors in the global urgent care apps market? 

The global urgent care apps market is fragmented in nature, owing to the presence of various key companies. The companies offer a diverse product portfolio of mobile apps operating in a variety of areas such as pre-, post-, and in-hospital communication and collaboration, medication adherence, triaging communication, and consultation. North America and Europe currently represent the hub of technology innovation.      

Urgent Care App Market

           

RELATED MARKET REPORTS 



ABOUT BIS HEALTHCARE

 BIS healthcare vertical offers intelligence in the healthcare technology market for precision medicine, robotics and imaging, life sciences and biopharma, medical devices, digital health, and other emerging healthcare technologies, covering the entire industry spectrum. In the past eight years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating ‘Top 25 Voices’ in precision medicine on its InsightMonk platform for the past two years successfully.


                                                                                                                                                                        



 


Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...